Frontline Pharmaceuticals Private Limited
About Frontline Pharmaceuticals Private Limited
Data last updated:
Frontline Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 August 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PTC057712. Its GSTIN is 27AAACF2040C1ZD (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹7.42 Lakh. It is led by directors including Mahesh Rajpal and Sangeeta Rajpal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 14 Siddhi Vinayak Industrial Estate Valiv Village Vasai (East), Thane, Maharashtra, India – 401202.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.21 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹4.45 Lakh (net margin 0.7%) and EBITDA of ₹10.02 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹30 Lakh and satisfied charges of ₹96.9 Lakh on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address14 Siddhi Vinayak Industrial Estate Valiv Village Vasai (East), Thane, Maharashtra, India – 401202
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Frontline Pharmaceuticals Private Limited
The main business activity of Frontline Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Frontline Pharmaceuticals Private Limited FY 2025 filings available
Frontline Pharmaceuticals Private Limited reported revenue of ₹6.21 Cr (down 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Frontline Pharmaceuticals Private Limited
Revenue fell 13% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Frontline Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.45 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Frontline Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Frontline Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Solu Clinipharm Private Limited | ₹6.24 Cr (FY 2021) | •••• | •••• | -20.0% | •••• | Thane, Maharashtra, India |
| Ritz Formulations Private Limited | ₹6.24 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Ahmedabad, Gujarat, India |
| Spectrum Medtech Private Limited | ₹6.23 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Sidhpur, Gujarat, India |
| CGMP Pharma 'N' Plans Private Limited | ₹6.22 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | New Delhi, Delhi, India |
| Sciegen Pharmaceuticals India Private Limited | ₹6.22 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Hyderabad, Telangana, India |
| Frontline Pharmaceuticals Private Limited this company | ₹6.21 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Thane, Maharashtra, India |
| Naturayuva India Private Limited | ₹6.19 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Mumbai, Maharashtra, India |
| Accent Biosciences Private Limited | ₹6.19 Cr (FY 2025) | •••• | •••• | 1512821.0% | •••• | Ahmedabad, Gujarat, India |
| Shri Sai Balaji Pharmatech Private Limited | ₹6.17 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Chandigarh, India |
| Katzung Pharmaceuticals Private Limited | ₹6.17 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Sruzam Labs Private Limited | ₹6.17 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Sampa, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Frontline Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals Private Limited is audited by DEEPAK D. AGRAWAL AND ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK D. AGRAWAL AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Rajpal | Director | 01 Aug 2009 | 17 Years 2 Months | Current |
| Sangeeta Rajpal | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
| Shivang Raj Pal | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of Frontline Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Frontline Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jun 2020 | Others | ₹30 Lakh | Open |
| 10 Mar 2008 | The Malad Sahakari Bank Limited | ₹30 Lakh | Satisfied |
| 03 May 1999 | The Malad Sahakari Bank Limited | ₹30 Lakh | Satisfied |
| 22 Jul 1997 | The Malad Sahakari Bank Ltd. | ₹18 Lakh | Satisfied |
| 22 Jul 1997 | The Malad Sahakari Bank Ltd. | ₹18.9 Lakh | Satisfied |
Total charge records: 5 View all charges
Legal Cases of Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals Private Limited has 8 court cases on record: 2 filed by Frontline Pharmaceuticals, 6 filed against it. 1 case is pending and 7 are disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 5 | 1 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CHOCL) | Filed against the company by Glenmark Pharmaceuticals Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Glenmark Pharmaceuticals Limited | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Glenmark Pharmaceuticals Limited | Disposed |
| Bombay High Court | Appeal | Filed by the company against Official Liquidator of M/S.Frontline Pharmaceuticals Pvt.Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed against the company by an individual | Disposed |
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Frontline Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Frontline Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals Private Limited has 7 board changes on record since 2009: 3 appointments and 4 cessations. The latest: Sangeeta Rajpal was appointed as Director on 24 Aug 2020.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Frontline Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Frontline Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Frontline Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF2040C1ZD | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Frontline Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Frontline Pharmaceuticals Private Limited
Frontline Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 August 1990 (36+ years old) and is registered under CIN U24230MH1990PTC057712.
Frontline Pharmaceuticals reported revenue of ₹6.21 Cr for FY 2025 (down 13% YoY).
Frontline Pharmaceuticals has 3 current directors:
- Mahesh Rajpal - Director
- Sangeeta Rajpal - Director
- Shivang Raj Pal - Director
Frontline Pharmaceuticals reported a net profit of ₹4.45 Lakh (net margin 0.7%) and EBITDA of ₹10.02 Lakh (EBITDA margin 1.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Frontline Pharmaceuticals is -5% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Frontline Pharmaceuticals is 27AAACF2040C1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Frontline Pharmaceuticals is U24230MH1990PTC057712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Frontline Pharmaceuticals has 8 court cases on record: 2 filed by the company and 6 filed against it. 1 is pending. Most are in the high courts.
Frontline Pharmaceuticals was incorporated on 14 August 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Frontline Pharmaceuticals by revenue are Solu Clinipharm Private Limited, Ritz Formulations Private Limited, Spectrum Medtech Private Limited, CGMP Pharma 'N' Plans Private Limited, Sciegen Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sangeeta Rajpal was appointed as Director on 24 Aug 2020. Shivang Raj Pal was appointed as Director on 24 Aug 2020. Khushi Ram Rajpal ceased to be Director on 08 Aug 2020. Frontline Pharmaceuticals has 7 board changes on record in total.